MedTrace Logo

A Clinical Trial to Compare and Evaluate Evaluate the Pharmacokinetics and Safety of CKD-846

NCT06110923 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 31

Last updated 2026-01-14

No results posted yet for this study

Summary

A Clinical trial to compare and evaluate evaluate the pharmacokinetics and safety of CKD-846

Conditions

  • Benign Prostate Hypertrophy(BPH)

Interventions

DRUG

CKD-846

once administration of Investigational Product

DRUG

D091

once administration of Investigational Product per day

Sponsors & Collaborators

  • Chong Kun Dang Pharmaceutical

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
19 Years
Max Age
55 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-11-13
Primary Completion
2024-05-10
Completion
2025-03-25

Countries

  • South Korea

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06110923 on ClinicalTrials.gov